Galapagos Initiates Clinical Studies With GLPG0492, A Candidate Drug For Cachexia

Galapagos Initiates Clinical Studies With GLPG0492, A Candidate Drug For Cachexia
Galapagos NV (Euronext: GLPG) announced that it has initiated a first-in-human trial for GLPG0492, its candidate drug for cachexia (loss of weight and muscle mass) and potentially other indications, such as Duchenne muscular dystrophy. GLPG0492 is an orally available small molecule that Galapagos has developed in its Selective Androgen Receptor Modulator (SARM) program. The candidate drug has …

Read more on Medical News Today

More Meth Drug Addiction Info:

• File Under? » Double Bill at Galapagos on 5/21
• Galapagos protection | This and That Online Blog
• galapagos cruises | Wanderlust
• cancer cachexia prognosis
• Awesome Exercises For Building Lean Muscle Mass « 1st Class Trader
• An Overview Of Unintended Weight Loss And Cachexia
• Increase Muscle Mass, Mood And Athletic Prowess By Using A Protein …
• Scientists Spot Real 'Smoking Gun' in Prostate Cancer | Stop smoking
• Natural Size – How To Build Muscle Mass. | Pharmacy Online Shop Blog
• Terrell Owens Bodylastics Fitness – 6 Top Methods To Build Muscle …